This inventor holds 2 USPTO granted patents. Top assignee: Isis Pharmaceuticals, Inc.. Active years: 2007-2010.
Company Filing History:
Years Active: 2007-2010
Title: John R Shutter: Innovator in Antisense Technology
Introduction
John R Shutter is a notable inventor based in Moorpark, CA (US). He has made significant contributions to the field of biotechnology, particularly in the modulation of gene expression. With a total of 2 patents, his work focuses on innovative methods for treating diseases associated with specific gene expressions.
Latest Patents
John R Shutter's latest patents revolve around the modulation of forkhead box O1A expression. These patents provide antisense compounds, compositions, and methods aimed at modulating the expression of forkhead box O1A. The compositions include antisense oligonucleotides that target nucleic acids encoding forkhead box O1A. The methods outlined in these patents are particularly relevant for treating diseases associated with the expression of forkhead box O1A, with a specific emphasis on diabetes.
Career Highlights
John R Shutter is associated with Isis Pharmaceuticals, Inc., where he has been instrumental in advancing research in antisense technology. His innovative approaches have contributed to the development of therapeutic strategies that address critical health issues.
Collaborations
Some of his notable coworkers include Murielle M Veniant-Ellison and Kenneth W Dobie. Their collaborative efforts have further enhanced the research and development initiatives at Isis Pharmaceuticals, Inc.
Conclusion
John R Shutter's work exemplifies the impact of innovative research in biotechnology. His contributions to the modulation of gene expression are paving the way for new treatments for diseases like diabetes.